203 related articles for article (PubMed ID: 16378435)
1. Gold nanoparticles as carriers for efficient transmucosal insulin delivery.
Joshi HM; Bhumkar DR; Joshi K; Pokharkar V; Sastry M
Langmuir; 2006 Jan; 22(1):300-5. PubMed ID: 16378435
[TBL] [Abstract][Full Text] [Related]
2. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin.
Bhumkar DR; Joshi HM; Sastry M; Pokharkar VB
Pharm Res; 2007 Aug; 24(8):1415-26. PubMed ID: 17380266
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
Damgé C; Maincent P; Ubrich N
J Control Release; 2007 Feb; 117(2):163-70. PubMed ID: 17141909
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
6. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
7. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
8. Electroporation of polymeric nanoparticles: an alternative technique for transdermal delivery of insulin.
Rastogi R; Anand S; Koul V
Drug Dev Ind Pharm; 2010 Nov; 36(11):1303-11. PubMed ID: 20849347
[TBL] [Abstract][Full Text] [Related]
9. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimisation and in vivo evaluation.
Graf A; Rades T; Hook SM
Eur J Pharm Sci; 2009 Apr; 37(1):53-61. PubMed ID: 19167488
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
Woitiski CB; Neufeld RJ; Veiga F; Carvalho RA; Figueiredo IV
Eur J Pharm Sci; 2010 Nov; 41(3-4):556-63. PubMed ID: 20800679
[TBL] [Abstract][Full Text] [Related]
12. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
Ma Z; Lim TM; Lim LY
Int J Pharm; 2005 Apr; 293(1-2):271-80. PubMed ID: 15778065
[TBL] [Abstract][Full Text] [Related]
16. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier.
Jain AK; Khar RK; Ahmed FJ; Diwan PV
Eur J Pharm Biopharm; 2008 Jun; 69(2):426-35. PubMed ID: 18295464
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
18. Buccal administration of human insulin in streptozocin-diabetic rats.
al-Achi A; Greenwood R
Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):297-306. PubMed ID: 8122030
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
Reis CP; Ribeiro AJ; Houng S; Veiga F; Neufeld RJ
Eur J Pharm Sci; 2007 Apr; 30(5):392-7. PubMed ID: 17280820
[TBL] [Abstract][Full Text] [Related]
20. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
